Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
1(8%)
Results Posted
36%(4 trials)

Phase Distribution

Ph phase_3
2
15%
Ph not_applicable
1
8%
Ph phase_2
3
23%
Ph phase_1
3
23%
Ph phase_4
3
23%

Phase Distribution

3

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
3(25.0%)
Phase 2Efficacy & side effects
3(25.0%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
3(25.0%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(11)

Detailed Status

Completed11
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (25.0%)
Phase 23 (25.0%)
Phase 32 (16.7%)
Phase 43 (25.0%)
N/A1 (8.3%)

Trials by Status

completed1185%
not_yet_recruiting18%
active_not_recruiting18%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT06817421Phase 4

Opportunistic Pneumococcal Immunisation Trial in MALnutrition

Not Yet Recruiting
NCT00622843Phase 3

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

Completed
NCT04945681Phase 4

Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced People

Active Not Recruiting
NCT06698198Phase 1

Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)

Completed
NCT02547493Not Applicable

Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients

Completed
NCT03109600Phase 1

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Completed
NCT02892812Phase 1

A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

Completed
NCT01229176Phase 2

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants

Completed
NCT01437267Phase 2

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants

Completed
NCT00806195Phase 3

Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Completed
NCT00197821Phase 2

Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults

Completed
NCT01402245Phase 4

Targeting of Immune Response After Pneumococcal Vaccination

Completed
NCT00488800

Safety and Local Tolerability of Prevenar in Indian Children

Completed

All 13 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
13